Ftse Mib
38.531,37
1,40%
DAX
23.041,54
2,26%
S&P 500
5.521,52
-1,39%
NASDAQ
17.303,01
0,00%
Bitcoin
83.382,49
2,89%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cellectar Biosciences Inc (CLRB) Cellectar Biosciences Inc (CLRB) Notizie

Cellectar Biosciences Inc

CLRB
0,295
-0,0046 (-1,54%)
Pre Mercato
Ultimo aggiornamento: 13:05:26
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/3/202512:15EDGAR2Form 8-K - Current report
13/3/202512:05GLOBECellectar Biosciences Reports Financial Results for Year..
13/3/202511:50EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
13/3/202502:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202513:05GLOBECellectar Biosciences to Present at the 37th Annual Roth..
05/3/202514:05GLOBECellectar Biosciences to Report Full Year Financial Results..
18/2/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202522:32EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
07/2/202522:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/2/202514:05GLOBECellectar Biosciences to Present at the Oppenheimer 35th..
03/2/202522:57EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
31/1/202522:30EDGAR2Form 8-K - Current report
29/1/202522:16EDGAR2Form S-1 - General form for registration of securities under..
14/1/202512:01EDGAR2Form 8-K - Current report
13/1/202500:00GLOBECellectar Biosciences to Highlight 2025 Strategic..
10/12/202423:00GLOBECellectar Biosciences Provides Strategic Update on Clinical..
18/11/202413:15EDGAR2Form 8-K - Current report
18/11/202413:05GLOBECellectar Biosciences Reports Financial Results for Q3 2024..
18/11/202412:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202422:33EDGAR2Form 8-K - Current report
14/11/202422:47EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:05GLOBECellectar Biosciences and NorthStar Medical Radioisotopes..
13/11/202422:45EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
12/11/202414:05GLOBECellectar Biosciences and SpectronRx Partner to Manufacture..
11/11/202422:05GLOBECellectar Biosciences to Report Third Quarter Financial..
07/11/202412:40GLOBECellectar Selected to Present New Data from Phase 2..
01/11/202422:15EDGAR2Form 8-K - Current report
01/11/202422:00GLOBECellectar Biosciences Announces Compliance Regarding Filing..
29/10/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202422:03EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
29/10/202421:56EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
26/8/202412:40GLOBEIopofosine I 131 Featured in Two Separate Presentations at..
23/8/202423:15EDGAR2Form 8-K - Current report
23/8/202423:00GLOBECellectar to Restate Previously Issued Financial Statements..
15/8/202401:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/8/202423:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13/8/202412:45EDGAR2Form 8-K - Current report
13/8/202412:40GLOBECellectar Biosciences Reports Financial Results for Q2 2024..
09/8/202423:00EDGAR2Form 8-K - Current report
08/8/202423:15GLOBEUPDATE -- Cellectar Biosciences to Announce Second Quarter..
08/8/202422:05GLOBECellectar Biosciences to Announce First Quarter Financial..
23/7/202412:45EDGAR2Form 8-K - Current report
23/7/202412:40GLOBECellectar Biosciences’ Iopofosine I 131 Exceeds Primary..
22/7/202412:45EDGAR2Form 8-K - Current report
22/7/202412:40GLOBECellectar Biosciences Announces Exercise of Tranche B..
11/7/202423:37EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
Apertura: Min: Max:
Chiusura: 0,2996

La tua Cronologia

NASDAQ
CLRB
Cellectar Biosciences
DBI
2DMM
Short Dax K
USOTC
TRGNF
Transgene (CE)
DBI
3XJ5
INDBX RUS2000 DR 1C SK
USOTC
ATPMF
Antipa Minerals (PK)
USOTC
SBMSF
Danakali (PK)
USOTC
FDVXF
FenixOro Gold (CE)
DOWI
DJCIKW
DJ Commodity Index Kansa...
USOTC
TRIRW
Triterras (CE)
USOTC
TRUHF
Truly (PK)
COIN
SPABTC
DOWI
DJUSCX
DJ US Specialty Chemicals
USOTC
TKKEF
Tokyotokeiba (PK)
USOTC
ZFSVF
Zurich Financial Services (QX)
USOTC
AUTLF
Austal (PK)
USOTC
TSEQF
Tosei Reit Investment (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci